Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

3.1K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lung ultrasound feature tracking to quantify regional lung strain in mechanically ventilated pigs.

Respiratory research·2026
Same author

Photo Quiz: Persistent eyelash debris in a 10-year-old female.

Journal of clinical microbiology·2026
Same author

Acellular normothermic spleen perfusion resolves transcriptional and non-transcriptional mechanisms of steroid immunosuppression.

bioRxiv : the preprint server for biology·2026
Same author

Hypertrophic Lichen Sclerosus: A Form of "Atypical" Lichen Sclerosus in the Pathway to HPV-Independent Squamous Cell Carcinoma of the Vulva.

The American journal of surgical pathology·2026
Same author

Case Study of Fulminant Pyoderma Gangrenosum: Conservative Therapy-Cornerstone of Management.

International medical case reports journal·2026
Same author

Detection of mitochondrial DNA mutations in T cells following 5-FU or cisplatin exposure.

Cell reports. Medicine·2026
Same journal

Simultaneous Liver-kidney Versus Liver Transplantation Categorized by Pretransplant eGFR: Impact of the 2017 OPTN Policy.

Transplantation·2026
Same journal

Preformed Anti-DQ Alpha Donor-specific Antibodies and the Risk of Antibody-mediated Rejection After Kidney Transplantation.

Transplantation·2026
Same journal

People in Transplantation: Professor Nadey Hakim, MD, PhD, FRCS, FRCSGlas (Hon), FACS, President-Elect of The Transplantation Society.

Transplantation·2026
Same journal

IL-1 Receptor Blockade Modulates Inflammation During Sequential Perfusion in Ex Vivo Porcine Kidneys.

Transplantation·2026
Same journal

Regulatory T Cells Allosensitized Under the Blockade of CD80/CD86-CD28 Costimulation Prolonged Islet Allograft Survival.

Transplantation·2026
Same journal

Desensitization With Tocilizumab and IVIg: A Prospective Controlled Cohort Study in a Predominantly Black American Population.

Transplantation·2026
See all related articles

Related Experiment Video

Updated: Dec 9, 2025

Murine Full-thickness Skin Transplantation
07:59

Murine Full-thickness Skin Transplantation

Published on: January 2, 2017

20.8K

DNA-PKcs Inhibition Extends Allogeneic Skin Graft Survival.

David K Harrison1,2, Zachary J Waldrip1,2, Lyle Burdine1,3

  • 1Division of Surgical Research, University of Arkansas for Medical Sciences, Little Rock, AR.

Transplantation
|September 5, 2020
PubMed
Summary
This summary is machine-generated.

Inhibiting DNA-PKcs, a key immune response protein, significantly reduced skin graft rejection in mice. This finding offers a potential new strategy for improving transplant success by modulating immune responses.

More Related Videos

Xenograft Skin Model to Manipulate Human Immune Responses In Vivo
08:23

Xenograft Skin Model to Manipulate Human Immune Responses In Vivo

Published on: June 29, 2022

3.5K
Transplantation of Tail Skin to Study Allogeneic CD4 T Cell Responses in Mice
06:48

Transplantation of Tail Skin to Study Allogeneic CD4 T Cell Responses in Mice

Published on: July 25, 2014

13.6K

Related Experiment Videos

Last Updated: Dec 9, 2025

Murine Full-thickness Skin Transplantation
07:59

Murine Full-thickness Skin Transplantation

Published on: January 2, 2017

20.8K
Xenograft Skin Model to Manipulate Human Immune Responses In Vivo
08:23

Xenograft Skin Model to Manipulate Human Immune Responses In Vivo

Published on: June 29, 2022

3.5K
Transplantation of Tail Skin to Study Allogeneic CD4 T Cell Responses in Mice
06:48

Transplantation of Tail Skin to Study Allogeneic CD4 T Cell Responses in Mice

Published on: July 25, 2014

13.6K

Area of Science:

  • Immunology
  • Transplantation Biology
  • Molecular Medicine

Background:

  • Organ transplantation is vital but challenged by immune-mediated graft rejection.
  • DNA-dependent protein kinase catalytic subunit (DNA-PKcs) plays a role in cellular and humoral immunity.
  • Understanding DNA-PKcs's role in rejection is crucial for developing better immunosuppression therapies.

Purpose of the Study:

  • To investigate the role of DNA-PKcs in allogeneic skin graft rejection.
  • To evaluate the potential of DNA-PKcs inhibition as a strategy to prevent transplant rejection.

Main Methods:

  • Murine allogeneic skin grafts (BalbC to C57bl6) were used.
  • Mice were treated with either a DNA-PKcs inhibitor (NU7441) or a vehicle control.
  • Analysis included graft rejection, cytokine profiles, immune cell infiltration, and antibody production.

Main Results:

  • DNA-PKcs inhibition significantly prolonged skin graft survival (14 days vs. 9 days).
  • Inhibition reduced key pro-inflammatory cytokines (IL-2, IL-4, IL-6, IL-10, TNF-α, IFN-γ) and immune cell infiltration (CD3+ lymphocytes).
  • Reduced B cell and plasma cell populations correlated with decreased donor-specific antibodies, mediated partly by inhibiting NF-κB signaling.

Conclusions:

  • DNA-PKcs inhibition effectively reduces allogeneic skin graft rejection.
  • DNA-PKcs has a novel immunoregulatory role in controlling cytokine production and NF-κB signaling in transplant rejection.